Chromogranin A (CgA) and Pancreastatin (PcSt) as Predictors of Peptide Receptor Radionuclide Therapy (PRRT) Outcomes in Patients with Metastatic Well-Differentiated Neuroendocrine Tumors (mNETs)

NEUROENDOCRINOLOGY(2012)

引用 0|浏览0
暂无评分
关键词
pancreastatin,chromogranin,peptide,receptor,radionuclide,therapy,prrt,neuroendocrine,tumors
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要